Supported by Clinical Data Presented at IPOS 2023, Pediatric Indication for OSSIOfiber® Bio-Integrative Orthopedic Fixation Technology Obviates the Need for...
WASHINGTON--(BUSINESS WIRE)--#parkerhealth--Parker Health, Inc, a prominent biotech company, is delighted to introduce Dr. Tushar Hazra as its new Chief Technology...
SAN FRANCISCO, CA / ACCESSWIRE / December 6, 2023 / Napo Pharmaceuticals (Napo), a Jaguar Health, Inc. (NASDAQ:JAGX) family company,...
SAN FRANCISCO, CA / ACCESSWIRE / December 6, 2023 / Napo Pharmaceuticals (Napo), a Jaguar Health, Inc. (NASDAQ:JAGX) family company,...
BRENTWOOD, TN / ACCESSWIRE / December 5, 2023 / Odyssey Behavioral Healthcare, a leading provider of addiction, mental health, and...
Canalevia®-CA1 is the first and only treatment for chemotherapy-induced diarrhea (CID) in dogs to receive any type of approval from...
VANCOUVER, British Columbia, Dec. 02, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced it...
NEW YORK, NY / ACCESSWIRE / December 1, 2023 / By the end of the decade, projections suggest that market...
CHICAGO, IL / ACCESSWIRE / November 30, 2023 / On Dec. 1, World AIDS Day, Fred Says announced it is...
Top line data for Jaguar Health's pivotal phase 3 OnTarget trial of crofelemer for prophylaxis of diarrhea in adult cancer...
New screening for loneliness is the latest addition to the comprehensive mental health evaluation that also includes assessments for ADHD,...
Partnership Lets Patients in Supportive Housing Access Comprehensive Virtual Primary Care and Mental Health Services, Powered by Device Kiosks and...
VANCOUVER, BC / ACCESSWIRE / November 29, 2023 / Clairvoyant Therapeutics Inc. (www.clairvoyantrx.com), the clinical-stage pharmaceutical company developing psilocybin therapy...
Twenty-seven percent of workers prioritize wellbeing support over salary increase CHICAGO, Nov. 29, 2023 (GLOBE NEWSWIRE) -- TELUS Health today...
Chicago, Illinois and Toronto, Ontario--(Newsfile Corp. - November 28, 2023) - Wesana Health Holdings Inc. (CSE: WESA.X) (OTCQB: WSNAF) (the "Company"), announced...
BRENTWOOD, TN / ACCESSWIRE / November 28, 2023 / Odyssey Behavioral Healthcare, a leading provider of mental health, eating disorder,...
SEATTLE, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced...
NMRA-266 is a highly selective positive allosteric modulator of the M4 muscarinic receptor, a clinically validated target for the treatment...
LONDON, Nov. 24, 2023 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access...
– Fast Track Designation accelerates ADP101's development path for the treatment of mono- and multi-food allergy – – Phase 1/2...